baber/WOPTO huggingface dataset:
Patent CY-1117488-T1 (CY)
Title: Διαταξη συνδεσης
Inventor: SENF DANIEL F
IPC: E02D17/20
Filed: 2016-01-11
Abstract: Μία διάταξη σύνδεσης για την πρόσδεση δύο ενισχυμένων δομών κυτταρικού περιορισμού συμπεριλαμβάνει ένα μέλος εισαγωγής το οποίο διαθέτει ένα πρώτο και ένα δεύτερο άκρο εισαγωγής τα οποία βρίσκονται απέναντι το ένα από το άλλο και μία επέκταση ενός μέλους εισαγωγής μεταξύ αυτών. Ένας ενιαίος κορμός εκτείνεται από την επέκταση του μέλους εισαγωγής και είναι αποστασιοποιημένο από κάθε ένα από το πρώτο και το δεύτερο άκρο εισαγωγής. Ένα μέλος λαβής εκτείνεται γενικά από τον κορμό σε ένα άκρο του κορμού το οποίο είναι απομακρυσμένο από το μέλος εισαγωγής. Το μέλος της λαβής έχει ένα πρώτο και ένα δεύτερο άκρο λαβής και ένα μέλος επέκτασης της λαβής ανάμεσα σε αυτά. Ο κορμός είναι αποστασιοποιημένος από κάθε ένα από το πρώτο και το δεύτερο άκρο της λαβής. Ένα κυτταρικό σύστημα περιορισμού περιλαμβάνει έναν πρώτο και έναν δεύτερο μοναδιαίο ιστό των κυττάρων οι οποίοι είναι κατασκευασμένοι από επιμήκεις πλαστικές λωρίδες που είναι δεμένες μεταξύ τους σε αποστασιοποιημένες μεταξύ τους περιοχές. Οι λωρίδες διαμορφώνουν τοιχώματα των κυττάρων και τουλάχιστον κάποια από τα κύτταρα προσδιορίζουν ανοικτές σχισμές. Τουλάχιστον μία ανοικτή σχισμή ενός πρώτου μοναδιαίου ιστού είναι ευθυγραμμισμένη με τουλάχιστον μία ανοικτή σχισμή ενός δεύτερου μοναδιαίου ιστού των κυττάρων, ούτως ώστε να καταλήξει σε μία περιοχή επικάλυψης του κυττάρου. Η περιοχή επικάλυψης του κυττάρου έχει μία πρώτη και μία δεύτερη πλευρά οι οποίες είναι απέναντι η μία από την άλλη. Τουλάχιστον μία διάταξη σύνδεσης προσδένει τον πρώτο μοναδιαίο ιστό των κυττάρων και τον δεύτερο μοναδιαίο ιστό των κυττάρων μεταξύ τους. Μία μέθοδος της πρόσδεσης δύο ενισχυμένων δομών κυτταρικού περιορισμού περιλαμβάνει την ευθυγράμμιση δύο ενισχυμένων δομών κυτταρικού περιορισμού, ούτως ώστε τουλάχιστον μία ανοικτή σχισμή η οποία προσδιορίζεται από έναν πρώτο μοναδιαίο ιστό των κυττάρων να είναι ευθυγραμμισμένη με τουλάχιστον μία ανοικτή σχισμή η οποία είναι προσδιορισμένη από ένα δεύτερο μοναδιαίο ιστό των κυττάρων, ούτως ώστε να διαμορφωθεί μία περιοχή επικάλυψης η οποία διαθέτει μία πρώτη και μία δεύτερη πλευρά, την εισαγωγή ενός μέλους εισαγωγής μίας διάταξης σύνδεσης από τη δεύτερη πλευρά της περιοχής επικάλυψης μέσω των ευθυγραμμισμένων ανοικτών σχισμών της περιοχής επικάλυψης, ούτως ώστε να παρασχεθεί: το μέλος εισαγωγής επί της πρώτης πλευράς της περιοχής επικάλυψης, ένα μέλος λαβής της διάταξης της σύνδεσης στη δεύτερη πλευρά της περιοχής επικάλυψης, και ένα μέλος ενός κορμού ανάμεσα στο μέλος εισαγωγής και το μέλος της λαβής το οποίο εκτείνεται μέσω της περιοχής επικάλυψης.
Patent CY-1124747-T1 (CY)
Title: Ανθρωπινα αντισωματα σε pd-1
Inventor: PAPADOPOULOS NICHOLAS J
IPC: C07K16/28
Filed: 2021-11-24
Abstract: Η παρούσα εφεύρεση παρέχει αντισώματα τα οποία συνδέονται με μια προγραμματισμένη πρωτεΐνη θανάτου-1 (PD-1) συν-αναστολέα Τ-κυττάρων. Σε διάφορες ενσωματώσεις της εφεύρεσης, τα αντισώματα είναι ανθρώπινα αντισώματα τα οποία συνδέονται στο PD-1. Σε ορισμένες ενσωματώσεις, η παρούσα εφεύρεση παρέχει πολυειδικά μόρια δέσμευσης αντιγόνου τα οποία περιλαμβάνουν μια πρώτη ειδικότητα δέσμευσης τα οποία συνδέονται στο PD-1 και μια δεύτερη ειδικότητα δέσμευσης τα οποία συνδέονται σε ένα αυτοάνοσο αντιγόνο ιστού, ένα άλλο υποδοχέα Τ-κυττάρων, έναν υποδοχέα Fc, ή έναν υποδοχέα Τ-κυττάρων. Σε μερικές ενσωματώσεις, τα αντισώματα της εφεύρεσης είναι χρήσιμα για την αναστολή ή την εξουδετέρωση της δραστηριότητας του PD-1. και επομένως παρέχοντας ένα μέσο για την θεραπεία μιας ασθένειας ή διαταραχής όπως ο καρκίνος, η χρόνια ιογενής λοίμωξη. Σε άλλες ενσωματώσεις, τα αντισώματα είναι χρήσιμα για την ενίσχυση ή διέγερση της δραστηριότητας του PD-1, και επομένως παρέχοντας ένα μέσο για τη θεραπεία, για παράδειγμα, μιας αυτοάνοσης ασθένειας ή διαταραχής.
Patent CY-1124920-T1 (CY)
Title: Συνδεσμος ευκαμπτου σωληνα φορτωσης ανοικτης θαλασσας
Inventor: AARSNES JAN VIDAR
IPC: B67D9/00
Filed: 2022-01-19
Abstract: Σύνδεσμος εύκαμπτου σωλήνα φόρτωσης ανοικτής θάλασσας (9) με ένα άκρο συνδέσμου (13) και ένα άκρο εύκαμπτου σωλήνα (15), μια διάταξη προσγείωσης και καθοδήγησης (21) και μια φλάντζα συνδέσμου (14). Η διάταξη προσγείωσης και καθοδήγησης έχει ένα χώρο υποδοχής (28) που υποδέχεται μια καμπυλωτή άνω άκρη φλάντζας μιας φλάντζας σύνδεσης (7). Ο χώρος υποδοχής περιορίζεται προς τα πάνω και πλευρικά από τουλάχιστον δύο όψεις προσγείωσης και ολίσθησης (24) που εκτείνονται αξονικά πέρα από τη φλάντζα συνδέσμου σε κατεύθυνση αντίθετη σε σχέση με το άκρο εύκαμπτου σωλήνα. Οι όψεις προσγείωσης και ολίσθησης (24) κατανέμονται κατά μήκος μιας καμπύλης που αντιστοιχεί σε μια καμπυλωτή άνω άκρη φλάντζας (8) της φλάντζας σύνδεσης (7). Οι δύο κατώτερες όψεις προσγείωσης και ολίσθησης επιτρέπουν την είσοδο της φλάντζας σύνδεσης (7) μέσα στο χώρο υποδοχής (28) κατά μήκος μιας κατακόρυφης κατεύθυνσης. Μια όψη προσγείωσης και ολίσθησης (24) είναι διατεταγμένη στις αντίστοιχες πλευρές ενός κατακόρυφου επιπέδου που εκτείνεται διαμέσου της αξονικής κεντρικής γραμμής (26).
Patent GR-890300138-T1 (GR)
Title: Catalyst support material containing lanthanides
Inventor: SPOONER JAMES P
IPC: B01J37/02
Filed: 1990-03-14
Abstract: A catalyst undercoat (wash-coat) material comprising a plurality of stable, highly porous, co-precipitated agglomerated crystallites comprised of integral admixture of alumina and at least one lanthanide oxide. The co-precipitated material may be converted to a slurry and used as an undercoat or wash-coat atop a prefabricated low surface area support. Alternatively, the co-precipitated material may be compressed or extruded into various geometric forms and these can be used as a support and as such serve both as the support and the undercoat.
Patent HR-P20090673-T1 (HR)
Inventor: GUILLEMONT J E G
IPC: C07D215/38
Filed: 2009-12-16
Abstract: Spoj prema općoj Formuli (Ia) ili općoj Formuli (Ib) njegove farmaceutski prihvatljive kisele ili bazne adicijske soli, njegovi kvaterni amini, njegovi stereokemijski izomerni oblici, njegovi tautomerni oblici i njegovi N-oksidni oblici, naznačen time da: R1	je vodik, halo, haloalkil, cijano, hidroksi, Ar, Het, alkil, alkiloksi, alkiltio, alkiloksialkil, alkiltioalkil, Ar-alkil ili di(Ar)alkil; p	je cijeli broj jednak 1, 2 ili 3; R2	je vodik; alkil; hidroksi; tio; alkiloksi po izboru supstituiran sa amino ili mono ili di(alkil)amino ili radikalom formule pri čemu Z je CH2, CH-R10, O, S, N-R10 i t je cijeli broj jednak 1 ili 2, i isprekidana crta predstavlja vezu po izboru; alkiloksialkiloksi; alkiltio; mono ili di(alkil)amino pri čemu alkil može po izboru biti supstituiran sa jednim ili dva supstituenta od kojih je svaki nezavisno izabran između alkiloksi ili Ar ili Het ili morfolinil ili 2-oksopirolidinil; Ar, Het ili radikal formule pri čemu Z je CH2, CH-R10, O, S, N-R10; t je cijeli broj jednak 1 ili 2; i isprekidana crta predstavlja vezu po izboru; R3	je alkil, Ar, Ar-alkil, Het ili Het-alkil; q	je cijeli broj jednak nuli, 1, 2, 3 ili 4; X	je direktna veza ili CH2;R4 i R5	svaki nezavisno su vodik, alkil ili benzil; iliR4 i R5	zajedno i uključujući N na kojeg su vezani mogu tvoriti radikal izabran iz skupine koja sadrži pirolidinil, 2H-pirolil, 2-pirolinil, 3-pirolinil, pirolil, imidazolidinil, pirazolidinil, 2-imidazolinil, 2-pirazolinil, imidazolil, pirazolil, triazolil, piperidinil, piridinil, piperazinil, imidazolidinil, piridazinil, pirimidinil, pirazinil, triazinil, morfolinil i tiomorfolinil, svaki od navedenih prstena po izboru supstituiran sa alkil, halo, haloalkil, hidroksi, alkiloksi, amino, mono- ili dialkilamino, alkiltio, alkiloksialkil, alkiltioalkil i pirimidinil; R6	je vodik ili radikal formulepri čemu s je cijeli broj jednak nuli, 1, 2, 3 ili 4; r je cijeli broj jednak 1, 2, 3, 4 ili 5; i R11 je vodik, halo, haloalkil, hidroksi, Ar, alkil, alkiloksi, alkiltio, alkiloksialkil, alkiltioalkil, Ar-alkil ili di(Ar)alkil; ili dva susjedna R11 radikala mogu se zajedno uzeti da sa fenilnim prstenom na kojeg su vezani tvore naftil; R7	je vodik, alkil, Ar ili Het; R8	je vodik ili alkil; R9	je okso; R10	je vodik, alkil, hidroksil, aminokarbonil, mono- ili di(alkil)aminokarbonil, Ar, Het, alkil supstituiran sa jednim ili dva Het, alkil supstituiran sa jednim ili dva Ar, Het-C(=O)-, Ar-C(=O)-; alkil	je ravan ili razgranat zasićeni radikal ugljikovodika koji ima od 1 do 6 atoma ugljika; ili je ciklički zasićeni radikal ugljikovodika koji ima od 3 do 6 atoma ugljika; ili je ciklički razgranat radikal ugljikovodika koji ima od 3 do 6 atoma ugljika vezan na ravan ili razgranat zasićeni radikal ugljikovodika koji ima od 1 do 6 atoma ugljika; pri čemu svaki atom ugljika može po izboru biti supstituiran sa halo, hidroksi, alkiloksi ili okso; Ar	je homoprsten izabran iz skupine koja sadrži fenil, naftil, acenaftil, tetrahidronaftil, svaki po izbo
Patent SI-1281655-T1 (SI)
Title: Landing door
IPC: E05F17/00
Filed: 2002-07-08
Abstract: Lift well door comprises a door frame, a door leaf (1) made from panels (2, 3) guided on a runner (5), and rails (9) for guiding the runner arranged in the upper sleeper (21) of the frame. The panel (3) is connected to the ends of a cable (7) which is guided on the upper side of the other panel (2) via deviating rollers (8). The rails consist of hollow profiles into which the rollers (13) of the runner are inserted. The deviating rollers are arranged with their vertical axles (10) between the upper side of the panel (2) and the rails assigned to this panel. Preferred Features: The hollow profiles having wedge-shaped running surfaces (12) on which the runner is centered. The hollow profiles are strand-like profiles or groove profiles.
Patent SI-1373639-T1 (SI)
Title: A vibration damping system
Inventor: ASMUSSEN JOHN
IPC: E01B1/00
Filed: 2002-04-04
Abstract: The vibration damping system, especially for use in the damping of vibrations e.g. from trains, tramcars, other traffic and damping of ground borne vibrations in general, comprises an anti-vibration plate in the form of a plate having a first and a second major surface. The anti-vibration plate comprises mineral fibers, a non-foamed polymeric material and/or a polymeric foam. The anti-vibration plate can further be provided with one or more hollow spaces, i.e. cavities. The anti-vibration plate is obtainable by a method comprising the step of subjecting an area of the opposite surface of the plate to a compression treatment in one or more steps, which compression treatment is sufficient to reduce the static and/or dynamic stiffness of the plate.
Patent SI-1539803-T1 (SI)
Title: Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity
Inventor: DAL POZZO ALMA
IPC: G01N33/00
Filed: 2003-07-18
Abstract: Compounds of formula (I) cyclo [NX1-R1-CO-NX2-R2-CO-NX3-R3-CO-NX4-CO-NX5-R5-CO], wherein at least one x-fluoroalkylated amino acid is present, are inhibitors of integrins, particularly those belonging to the alphavbeta3 and alphavbeta5 family, and thus are useful as medicaments, particularly for the treatment of the underlying diseases responsible for abnormal angiogenesis, such as retinopathy, acute kidney failure, osteoporosis and metastases. The compounds described herein are also useful as diagnostic agents, when appropriately labelled, especially for the detection and location of small tumour masses and arterial occlusion events.
Patent SI-1641461-T1 (SI)
Title: Combination product comprising an antagonist or inverse agonist of histamine receptor h3 and an antipsychotic or antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drug
Inventor: SCHWARTZ JEAN-CHARLES
IPC: A61K31/4164
Filed: 2004-06-25
Abstract: Medicament comprising, in a pharmaceutically acceptable vehicle, an anti-psychotic or an antidepressant (A), which, on its own, has an undesirable effect of a gain in body weight or sedation, and an antagonist and/or inverse agonist (B) of the histamine H3 receptor, the antagonist and/or inverse agonist of the histamine H3 receptor being present in a therapeutically effective amount for ensuring at least one of the following three effects: suppression or at least limitation of the undesirable effect of weight gain, suppression or limitation of the undesirable effect on alertness, epilepsy/convulsions, increase in the precognitive effect of the treatment. Use of such an antagonist or inverse agonist for the preparation of a medicament which is to ensure at least one of the said three effects in a patient treated by such an antipsychotic or antidepressant.
Patent SI-1773757-T1 (SI)
Title: Trpv1 agonists, formulations containing them and uses thereof
Inventor: MORAZZONI PAOLO
IPC: C07D303/46
Filed: 2005-07-06
Abstract: The compounds of the general formula (I) in which X is represents two hydrogen atoms, a pi-bond, oxygen or methylene: R2 is a C<SUB>6</SUB>-C<SUB>12 </SUB>aryl, or arylalkyl residue: R3 is hydrogen, 2-hydroxyethyl or 2-aminoethyl are useful for the treatment of pathologies mediated by vanilloid receptors type I.
Patent SI-1845649-T1 (SI)
Title: Method and apparatus for transmitting and receiving status report in a mobile communication system
Inventor: KIM SOENG-HUN
IPC: H04L1/00
Filed: 2007-04-16
Abstract: A method and apparatus for transmitting/receiving a status report in a mobile communication system where Automatic Repeat reQuest (ARQ) and Hybrid Automatic Repeat reQuest (HARQ) operate together. An ARQ receiving (Rx) entity determines whether transmission of the status report is permitted, if a predetermined status report generation condition is satisfied. If the transmission of the status report is permitted, the ARQ Rx entity generates a status report depending on a reception status of ARQ packets received up to the time the transmission of the status report is permitted, and transmits the generated status report to an ARQ transmitting (Tx) entity through an allocated transmission resource. The ARQ Tx entity determines an initial reception time of an HARQ packet including the status report as a generation time of the status report, and performs retransmission according to the status report.
Patent SI-2772265-T1 (SI)
Title: Recombinant HCMV and RHCMV vectors and uses thereof
Inventor: PICKER LOUIS
IPC: C12N15/00
Filed: 2011-05-16
Abstract: Described herein are recombinant rhesus cytomegalovirus (RhCMV) and human cytomegalovirus (HCMV) vectors encoding heterologous antigens, such as pathogen-specific antigens or tumor antigens. The recombinant vectors elicit and maintain high level cellular and humoral immune responses specific for the heterologous antigen. The recombinant RhCMV and HCMV vectors may be used, for example, for the treatment or prevention of infectious disease or cancer. In some examples, the recombinant RhCMV or HCMV vectors may include deletions in genes encoding immunomodulatory proteins. In some examples, the recombinant RhCMV or HCMV vectors may be deficient or impaired in their ability to replicate within a cell, disseminate within the host or spread among hosts by including a deletion in one or more genes essential or augmenting for CMV replication, dissemination or spread.
Patent SI-2686334-T1 (SI)
Title: Ion exchange chromatography with improved selectivity for the separation of polypeptide monomers, aggregates and fragments by modulation of the mobile phase
Inventor: NEUMANN SEBASTIAN
IPC: C07K16/00
Filed: 2012-03-14
Abstract: Herein is reported a method for producing a polypeptide in monomeric form comprising the following step: recovering the polypeptide in monomeric form from an ion exchange chromatography material by applying a solution comprising a non- ionic polymer and an additive.
Patent TR-200200689-T1 (TR)
Title: Dar açıda kilitleme yapabilen boru kelepçesi
Inventor: TANRITANI CETIN
IPC: F16L55/035
Filed: 2001-07-20
Abstract: Alt parça (1) üzerinde vidanin (7) dogrudan takilabilecegi vida deligi (3) açilmistir. Üst parçanin (2) etek kismina birbirini tamamlayan iki degisik çapli dairesel bosluk (4) yapilmistir. Genis çapli dairesel bosluk (4) vida (7) basinin kolay geçebilecegi genisliktedir. Alt parçanin (1) bir ucuna bir baglanti yuvasi (5) açilmis ve üst parçanin (2) bir ucu dil seklinde (6) düzenlenmistir. Üst parçanin dil seklindeki ucu (6), alt parçanin (1) baglanti yuvasina (5) takilir. Birbirine takilan alt (1) ve üst (2) parçalar üzerine tek parça halinde olan kelepçe lastigi (8) geçirilir. Alt parçadaki (1) vida deligine (3) vidalanan vidanin (7) basi genis bosluktan (4) takildiktan sonra, daha dar çapli bosluga (4) dogru hareketle yerlestirilir ve alt (1) ve üst (2) parçalarda es merkezlik saglanir.
Patent DE-3688492-T2 (DE)
Inventor: BAUMGARTNER ALAN SQUIER
IPC: C09B69/00
Filed: 1986-08-20
Granted: 1993-10-28
Abstract: A colored thermoplastic resin composition is provided which comprises a thermoplastic resin and a colorant in the form of an alkyleneoxy-substituted chromophore group provided in said thermoplastic resin in a minor amount sufficient to provide coloration to said thermoplastic resin. A process for preparing colored thermoplastic resins is also provided.
Patent DE-3751929-T2 (DE)
Inventor: KENNEDY JOSEPH PAUL
IPC: C08F297/00
Filed: 1987-08-25
Granted: 1997-06-05
Abstract: This invention provides a novel catalyst composed of a complex of an organic ether and a Lewis acid, preferably boron trichloride that can add olefin monomers to increase the molecular weight of the complex from as low as 200 to in excess of 100,000 preferably 500 or 1000 to 10,000 and higher, with the complex being active viz., living, until the complex dies, viz., is decomposed or destroyed so that polymers in the liquid or easily liquefiable range of 300 to about 10,000 and preferable 500 or 1000 to 10,000 and higher can be made or those more difficult to be liquefied or unliquefiable, viz., those of over 10,000 up to 100,000 and having useful end groups such as the halogens and specifically chloride.
Patent DE-3783048-T2 (DE)
Inventor: NAITO KENZO
IPC: C07D501/20
Filed: 1987-02-24
Granted: 1993-04-15
Abstract: A method for producing a compound of the formula;wherein R stands for a hydrogen atom, an acyl group or a protective group other than acyl groups, Q stands for a hydrogen atom or an ester residue, Y stands for the residue of a nucleophilic compound and the dotted line shows the double bond at 2- or 3- position of the cephem ring or a salt thereof, characterized by allowing a compound of the formula;[R, Q and the dotted line are of the same meaning as abovelor a salt thereof to react with a nucleophilic compound or a salt thereof and a compound of the formula;wherein R<sup>1</sup>, R<sup>2</sup> and R<sup>3</sup> independently stand for a hydrocarbon group having not more than 8 carbon atoms, or R' and R<sup>2</sup>, R<sup>1</sup> and R<sup>3</sup> or R<sup>2</sup> and R<sup>3</sup> may be combined to form polymethylene group, according to which the end product [I] of high quality can be provided in a high yield by one reaction step by using the compound [III] of relatively low cost, thus the method of this invention is advantageous for mass-producing the compound [I] on an industrial scale from the compound [II] and a nucleophilic compound.
Patent DE-3856121-T2 (DE)
Inventor: COOPER GARTH JAMES SMITH
IPC: C07K16/00
Filed: 1988-04-27
Granted: 1998-07-23
Abstract: Amylin has been found to be useful in the confirmation or prediction of diabetes mellitus and for use in treating vasodilation. Particular the sequence KCNTAT has been found to be significant in amylin and there are provided synthetic peptides containing sequences including KCNTAT. Also provided are synthetic amylin and amylin-like peptides, a substantially pure amylin, various hexa- and -heptapeptides related to amylin and processes for the preparation of DAP including a vector containing a genetic sequence coding for amylin.
Patent DE-3874222-T2 (DE)
Inventor: DRECHSEL ARNO
IPC: B05B3/04
Filed: 1988-04-21
Granted: 1993-01-07
Abstract: A self-adjusting rotary-arm irrigation sprinkler comprises an intermediate piece (8) between the propulsion tube (1) and rotary arm (13), which supports the rotary arm and whose position is adjustable in height relative to the propulsion tube by means connected to the propulsion tube.
Patent DE-3876392-T2 (DE)
Inventor: CARPENTER ROBERT B
IPC: C04B28/04
Filed: 1988-12-09
Granted: 1993-04-01
Abstract: Wellbores are cemented with a cement composition formed from drilling fluid occupying the wellbore by circulating a quantity of drilling fluid mixed with a cement material and a dispersant such as a sulfonated styrene copolymer with or without an organic acid into the wellbore to displace the drilling fluid and to continuously convert the drilling fluid into the cement composition. The cement composition may be recirculated through the space in the wellbore to completely evacuate any drilling fluid not converted to cement so as to minimize any faults in the cement composition occupying the wellbore. A preflush composition containing the dispersant and being rheologoically compatible with both the drilling fluid and the drilling fluid converted to cement slurry may be used as a displacement fluid.
Patent DE-3889541-T2 (DE)
Inventor: CALCAGNO PIERO
IPC: G05B19/35
Filed: 1988-12-27
Granted: 1994-08-25
Abstract: The device is intended to be used for recording the position reached by a moving part, such as the arm of an industrial robot moved by a rotary motor (M). The device comprises, in an assembly capable of being associated with the said moving part, an angular-position transducer such as a resolver (2), capable of generating at least one signal (4, 5) indicating the position reached by the motor (M) during a rotation, counting means (12) connected to the angular-position transducer (2), capable of storing a cumulative count of the signal generated by the transducer (2) itself and indicating the position reached by the moving part, and power supply means such as a buffer battery (18) capable of keeping the position transducer (2) and the counting means (12) active even when there is no external power supply.
Patent DE-3889884-T2 (DE)
Inventor: BARSOMIAN JANET
IPC: C12N9/10
Filed: 1988-12-16
Granted: 1995-01-05
Abstract: The present invention is directed to a method for cloning and producing the HinPI restriction endonuclease by 1) introducing the restriction endonuclease gene from Haemophilus influenza P1 into a host whereby the restriction gene is expressed; 2) fermenting the host which contains the vector encoding and expressing the HinPI restriction endonuclease, and 3) purifying the HinPI restriction endonuclease from the fermented host which contains the vector encoding and expressing the HinPI restriction endonuclease activity.
Patent TR-199800687-T2 (TR)
Inventor: VOS RIK DE
IPC: C08G18/80
Filed: 1996-09-24
Abstract: Silikon bazli bir yüzey aktif maddenin yoklugunda sert bir poliüretan veya üretanla degistirilmis poliizosiyanürat köpügü hazirlamak için bir islem olup, çok fonksiyonlu izosiyanat-reaktif bilesim aminle baslatilan bir polieter polyol ve istege bagli olarak fonksiyonalitesi 2 ila 6 ve sayisal ortalama molekül agirligi 1000 ve 10000 arasinda olan bir polieter polyol içerir ve istege bagli olarak poliizosiyanat bilesimi bir organik poliizosiyanatin stiokiometrik bir fazlaligi ile esas itibariyla fluorlu izosiyanat reaktif bilesigin reaksiyon ürününü içerir.
Patent TR-199901824-T2 (TR)
Inventor: SARAMA ROBERT JOSEPH
IPC: A23L33/20
Filed: 1998-01-09
Abstract: Processes for treating a polyol fatty acid polyester comprise feeding an unrefined polyol fatty acid polyester containing impurities and soap, and a wash solution into a mixing vessel and dispersing the contents to form a mixture. The treated mixture is allowed to settle and separate into a first phase comprising treated polyol fatty acid polyester and a second phase comprising the wash solution, soap and impurities. A treated polyol fatty acid polyester is produced by the processes described herein. Impurities soluble in the wash solution, such as color bodies, and the like are among the impurities which can be removed by the processes of the present invention. Chelating agents can be included in the wash solution to aid in the removal of impurities such as trace metals.                 00000